Eikon Therapeutics
Eikon Therapeutics offers a summer internship program in biostatistics that immerses interns in clinical trial design and analysis, focusing on adaptive oncology clinical trials. The program provides practical experience in statistical methodology, programming, and regulatory documentation within a collaborative biotech environment.
Headquarters
Millbrae, California, United States
Company Size
201-500 employees
Founded
2019
Eikon Therapeutics is a biotechnology company that advances breakthrough therapeutics through the purposeful integration of science and engineering. The company has built a proprietary discovery platform that combines high‑resolution structural and single‑particle imaging (including cryo‑EM), automated experimental engineering, and computational/AI methods to map protein conformational landscapes and identify novel small‑molecule modulators. That platform is used to accelerate target identification, structure‑enabled design, and lead optimization across multiple therapeutic areas through internal programs and external partnerships. Headquartered in Cambridge, MA, Eikon emphasizes an engineering‑first approach to tackle challenging protein targets and shorten drug discovery timelines.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Eikon Therapeutics.
IPO Tracker 2026: Generate Clocks Largest IPO Since 2024 With $400M Raise
2 weeks ago